Clinical Trial

OssiMend BA in Posterolateral Instrumented Lumbar Fusion

Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to measure the success rate of lumbar fusion in subjects at 12 months when instrumented lumbar arthrodesis is performed using OssiMend Bioactive Moldable as the bone grafting material
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-02-25; most recent amendment 2025-10-14.
Trial Details
NCT Number NCT04775537
Lead Sponsor Collagen Matrix
Conditions Spinal Disease, Degenerative Disc Disease
Enrollment 120 participants
Start Date 2021-01-21
Primary Completion 2026-12-30 (estimated)
Study Completion 2027-01-30 (estimated)
Updated on ClinicalTrials.gov 2025-10-16